RxDoctor Payments Data

Jason Heavens, MD

Family Medicine · Tempe, AZNPI 1063781797

Payments from drug & device makers

$1,334in general payments, 2019–2025

Across 80 payments — averaging $16.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$264
  • GSK$162
  • Boehringer Ingelheim$136
  • Abbott$125
  • Novo Nordisk$106
  • Lilly USA, LLC$68
  • plus $473 from 16 others

What the payments were for

  • Food & beverage$1,334100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,334 in reported general payments places this provider in the 75th percentile of 2,099 family medicine providers in Arizona.

See all family medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$80,863
Medicare patients
333
Services billed
1,027

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide86$101,021
EliquisApixaban75$84,509
JardianceEmpagliflozin59$67,543
Trelegy ElliptaFluticasone/Umeclidin/Vilanter77$63,708
TriumeqAbacavir/Dolutegravir/Lamivudi12$44,252
MyrbetriqMirabegron38$33,053
XareltoRivaroxaban18$19,078
LinzessLinaclotide20$17,027
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$6,382
Varenicline Tartrate25$5,671
Lantus SolostarInsulin Glargine,hum.Rec.Anlog35$5,660
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$5,380
Albuterol Sulfate HfaAlbuterol Sulfate158$4,181
Rosuvastatin Calcium221$4,056
Fluticasone-SalmeterolFluticasone Propion/Salmeterol13$3,150

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$106$101,02186 claims
PfizerEliquis$40$84,50975 claims
Boehringer IngelheimJardiance, Stiolto Respimat$136$72,92270 claims
GSKTrelegy Ellipta, Anoro Ellipta$162$70,09088 claims
Johnson & JohnsonXarelto$37$19,07818 claims
AbbVieLinzess$264$17,02720 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,099 family medicine providers in Arizona.

Other family medicine in Tempe

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →